These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 5790690

  • 1. Cancer treatment with sulfones.
    Graham J, Graham R.
    Surg Gynecol Obstet; 1969 Jul; 129(1):103-7. PubMed ID: 5790690
    [No Abstract] [Full Text] [Related]

  • 2. [Resistance formation in the cytostatic treatment of carcinomas].
    Heckmann U, Tranckjer AS, Harms J.
    Zentralbl Gynakol; 1969 Sep 13; 91(37):1204-10. PubMed ID: 5368211
    [No Abstract] [Full Text] [Related]

  • 3. Chemotherapy in gynecologic cancer.
    Savage EW, Maidman JE.
    Obstet Gynecol Annu; 1976 Sep 13; 5():339-430. PubMed ID: 185550
    [No Abstract] [Full Text] [Related]

  • 4. [Studies on additional Iscador therapy in the management of women with surgically and radiotherapeutically treated genital carcinoma].
    Leroi R.
    Gynaecologia; 1969 Sep 13; 167(3):158-70. PubMed ID: 4305038
    [No Abstract] [Full Text] [Related]

  • 5. Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva.
    Omura GA, Shingleton HM, Creasman WT, Blessing JA, Boronow RC.
    Cancer Treat Rep; 1978 May 13; 62(5):833-5. PubMed ID: 350400
    [No Abstract] [Full Text] [Related]

  • 6. Clinical experience gained in the treatment of advanced genital cancer by the application of the MBBA preparation.
    Dvorák O, Semonský M.
    Neoplasma; 1967 May 13; 14(2):135-44. PubMed ID: 4382232
    [No Abstract] [Full Text] [Related]

  • 7. Chemotherapy in gynecologic cancer.
    Smith JP.
    Clin Obstet Gynecol; 1975 Dec 13; 18(4):109-24. PubMed ID: 174855
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of an additional cytostatic treatment on the 5 year-long remission of operated genital carcinomas].
    Müller R, Baust G.
    Zentralbl Gynakol; 1968 Nov 30; 90(48):1609-23. PubMed ID: 5709576
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The use of cytotoxic chemotherapy in conjunction with gynaecological surgery.
    Guthrie D.
    Clin Obstet Gynaecol; 1978 Dec 30; 5(3):709-27. PubMed ID: 367674
    [No Abstract] [Full Text] [Related]

  • 11. [In vitro testing and clinical experience with 5-fluorouracil in gynaecologic cancer (author's transl)].
    Marzotko F, Krafft W, Preibsch W, Schröder M.
    Arch Geschwulstforsch; 1976 Dec 30; 46(2):140-5. PubMed ID: 962505
    [Abstract] [Full Text] [Related]

  • 12. Palliation chemotherapy of pelvic carcinoma by systemic, perfusion, and infusion modalities.
    Boutselis JG, Ullery JC, Pace W.
    Ohio State Med J; 1971 Aug 30; 67(8):721-5. PubMed ID: 4105456
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Experiences in the cytostatic treatment of cancer originating in the genitalia].
    Váczy L.
    Zentralbl Gynakol; 1965 Jul 31; 87(31):1075-82. PubMed ID: 5838635
    [No Abstract] [Full Text] [Related]

  • 15. Chemotherapy for gynecologic malignancies at Siriraj Hospital, Bangkok.
    Senapad S.
    Southeast Asian J Trop Med Public Health; 1985 Dec 31; 16(4):656-9. PubMed ID: 3939044
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Experiences on in vitro testing of cytostatic sensitivity (oncobiogram) in gynecological tumors].
    Krafft W, Preibsche W, Marzotko F.
    Arch Geschwulstforsch; 1973 Dec 31; 41(3):241-7. PubMed ID: 4732846
    [No Abstract] [Full Text] [Related]

  • 18. Clinical management and philosophy of treatment of pelvic cancer.
    Rutledge F.
    Proc Natl Cancer Conf; 1970 Dec 31; 6():333-41. PubMed ID: 5458100
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Distribution of some inherited blood characters, changes in fifth fraction of serum lactate dehydrogenase, and resistance to cytembena in women with gynaecological carcinoma.
    Milunicová A, Jandová A, Skoda V.
    Neoplasma; 1971 Dec 31; 18(2):219-24. PubMed ID: 5577318
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.